ArticleJournal of bone oncology2018

Effects on bone resorption markers of continuing pamidronate or switching to zoledronic acid in patients with high risk bone metastases from breast cancer.

J F Hilton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.